UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 266

Sortiert nach

How I treat thalassemia

Blood, 2011-09, Vol.118 (13), p.3479-3488

2011

Volltextzugriff (PDF)

Non-transfusion-dependent thalassemias

Haematologica (Roma), 2013-06, Vol.98 (6), p.833-844

2013

Volltextzugriff (PDF)

The role of oxidative stress in hemolytic anemia

Current molecular medicine, 2008-11, Vol.8 (7), p.609

2008

Volltextzugriff (PDF)

Iron overload in hematological disorders

La Presse médicale (1983), 2017-12, Vol.46 (12), p.e296-e305

2017

Volltextzugriff (PDF)

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome

Blood, 2014-08, Vol.124 (6), p.873-881

2014

Volltextzugriff (PDF)

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

Thrombosis and haemostasis, 2006-10, Vol.96 (4), p.488

2006

Volltextzugriff (PDF)

The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia

Annals of the New York Academy of Sciences, 2010-08, Vol.1202 (1), p.10-16

2010

Volltextzugriff (PDF)

Iron overload in MDS--pathophysiology, diagnosis, and complications

Annals of hematology, 2011-01, Vol.90 (1), p.1-10

2011

Volltextzugriff (PDF)

The hypercoagulable state in thalassemia

Blood, 2002-01, Vol.99 (1), p.36-43

2002

Volltextzugriff (PDF)

Cerebral infarction in β-thalassemia intermedia: Breaking the silence

Thrombosis research, 2012-11, Vol.130 (5), p.695-702

2012

Volltextzugriff (PDF)

β-thalassemia intermedia: a clinical perspective

Cold Spring Harbor perspectives in medicine, 2012-07, Vol.2 (7), p.a013482-a013482

2012

Volltextzugriff (PDF)

Pathophysiology and treatment of patients with beta-thalassemia - an update

F1000 research, 2017, Vol.6, p.2156-2156

2017

Volltextzugriff (PDF)

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

The Journal of clinical investigation, 2010-12, Vol.120 (12), p.4466-4477

2010

Volltextzugriff (PDF)

β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability

British journal of haematology, 2007-10, Vol.139 (1), p.3-13

2007

Volltextzugriff (PDF)

The Effect of Fermented Papaya Preparation on Radioactive Exposure

Radiation research, 2015-09, Vol.184 (3), p.304

2015

Volltextzugriff (PDF)

Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia

Thrombosis and haemostasis, 2010-05, Vol.103 (5), p.989

2010

Volltextzugriff (PDF)

Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron

European journal of haematology, 2012-07, Vol.89 (1), p.87-93

2012

Volltextzugriff (PDF)

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

Haematologica (Roma), 2010-08, Vol.95 (8), p.1433-1434

2010

Volltextzugriff (PDF)

THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL

Mediterranean journal of hematology and infectious diseases, 2014-03, Vol.6 (1), p.e2014022-e2014022

Rachmilewitz, Eliezer

2014

Volltextzugriff (PDF)

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Blood, 2007-06, Vol.109 (11), p.5027-5035

2007

Volltextzugriff (PDF)

Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL

Annals of the New York Academy of Sciences, 2009-09, Vol.1173 (1), p.865-873

2009

Volltextzugriff (PDF)

The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major

Annals of hematology, 2016-01, Vol.95 (1), p.135-139

2016

Volltextzugriff (PDF)

Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals

Annals of hematology, 2016-08, Vol.95 (8), p.1387-1387

2016

Volltextzugriff (PDF)

Increased serum hepcidin levels during treatment with deferasirox in iron‐overloaded patients with myelodysplastic syndrome

British journal of haematology, 2011-04, Vol.153 (1), p.118-120

2011

Volltextzugriff (PDF)

Does erythropoietin have a role in the treatment of β-hemoglobinopathies?

Hematology/oncology clinics of North America, 2014-04, Vol.28 (2), p.249

2014

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(223)

Publikationsform

Artikel
(264)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(177)
Science & Technology
(151)
Life Sciences & Biomedicine
(146)
Biological And Medical Sciences
(92)
Hematology
(89)
Medical Sciences
(87)
Female
(76)
Male
(72)
Hematologic And Hematopoietic Diseases
(64)
Adult
(60)
Diseases Of Red Blood Cells
(49)
Anemias. Hemoglobinopathies
(46)
Adolescent
(40)
Middle Aged
(31)
Child
(30)
Thalassemia - Blood
(28)
Beta-Thalassemia - Blood
(24)
Blood Transfusion
(21)
Thalassemia
(19)
Animals
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How I treat thalassemia

Non-transfusion-dependent thalassemias

The role of oxidative stress in hemolytic anemia

Iron overload in hematological disorders

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia

Iron overload in MDS--pathophysiology, diagnosis, and complications

The hypercoagulable state in thalassemia

Cerebral infarction in β-thalassemia intermedia: Breaking the silence

β-thalassemia intermedia: a clinical perspective

Pathophysiology and treatment of patients with beta-thalassemia - an update

Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice

β‐Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability

The Effect of Fermented Papaya Preparation on Radioactive Exposure

Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia

Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

THE PRICE OF MERCY: COMMENT TO THE PAPER "PREVENTION OF BETA-THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS” BY KOREN ET AL

Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin

Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL

The frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major

Frequency of silent cerebral ischemia in patients with transfusion-dependent β-thalassemia major compared to healthy individuals

Increased serum hepcidin levels during treatment with deferasirox in iron‐overloaded patients with myelodysplastic syndrome

Does erythropoietin have a role in the treatment of β-hemoglobinopathies?

Suchergebnisse filtern